178 related articles for article (PubMed ID: 2236008)
1. Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide.
Waddell T; Cohen A; Lingwood CA
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7898-901. PubMed ID: 2236008
[TBL] [Abstract][Full Text] [Related]
2. Verotoxin-resistant cell clones are deficient in the glycolipid globotriosylceramide: differential basis of phenotype.
Pudymaitis A; Armstrong G; Lingwood CA
Arch Biochem Biophys; 1991 May; 286(2):448-52. PubMed ID: 1910293
[TBL] [Abstract][Full Text] [Related]
3. Glycolipid modification of alpha 2 interferon binding. Sequence similarity between the alpha 2 interferon receptor and verotoxin (Shiga-like toxin) B-subunit.
Lingwood CA; Yiu SK
Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):25-6. PubMed ID: 1314564
[TBL] [Abstract][Full Text] [Related]
4. Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor.
Cohen A; Hannigan GE; Williams BR; Lingwood CA
J Biol Chem; 1987 Dec; 262(35):17088-91. PubMed ID: 2824515
[TBL] [Abstract][Full Text] [Related]
5. Verotoxin receptor glycolipid in human renal tissue.
Boyd B; Lingwood C
Nephron; 1989; 51(2):207-10. PubMed ID: 2644572
[TBL] [Abstract][Full Text] [Related]
6. Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease.
Cohen A; Madrid-Marina V; Estrov Z; Freedman MH; Lingwood CA; Dosch HM
Int Immunol; 1990; 2(1):1-8. PubMed ID: 1965141
[TBL] [Abstract][Full Text] [Related]
7. Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2.
Waddell T; Head S; Petric M; Cohen A; Lingwood C
Biochem Biophys Res Commun; 1988 Apr; 152(2):674-9. PubMed ID: 3284526
[TBL] [Abstract][Full Text] [Related]
8. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues.
Kiarash A; Boyd B; Lingwood CA
J Biol Chem; 1994 Apr; 269(15):11138-46. PubMed ID: 8157640
[TBL] [Abstract][Full Text] [Related]
9. Verotoxin/globotriaosyl ceramide recognition: angiopathy, angiogenesis and antineoplasia.
Lingwood CA
Biosci Rep; 1999 Oct; 19(5):345-54. PubMed ID: 10763802
[TBL] [Abstract][Full Text] [Related]
10. Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology.
Lingwood CA
Biochim Biophys Acta; 1999 Oct; 1455(2-3):375-86. PubMed ID: 10571026
[TBL] [Abstract][Full Text] [Related]
11. Globotetraosylceramide is recognized by the pig edema disease toxin.
DeGrandis S; Law H; Brunton J; Gyles C; Lingwood CA
J Biol Chem; 1989 Jul; 264(21):12520-5. PubMed ID: 2663859
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
Jacewicz M; Clausen H; Nudelman E; Donohue-Rolfe A; Keusch GT
J Exp Med; 1986 Jun; 163(6):1391-404. PubMed ID: 3519828
[TBL] [Abstract][Full Text] [Related]
13. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3.
Ling H; Boodhoo A; Hazes B; Cummings MD; Armstrong GD; Brunton JL; Read RJ
Biochemistry; 1998 Feb; 37(7):1777-88. PubMed ID: 9485303
[TBL] [Abstract][Full Text] [Related]
14. pH-independent retrograde targeting of glycolipids to the Golgi complex.
Schapiro FB; Lingwood C; Furuya W; Grinstein S
Am J Physiol; 1998 Feb; 274(2):C319-32. PubMed ID: 9486120
[TBL] [Abstract][Full Text] [Related]
15. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis.
O'Brien AD; Tesh VL; Donohue-Rolfe A; Jackson MP; Olsnes S; Sandvig K; Lindberg AA; Keusch GT
Curr Top Microbiol Immunol; 1992; 180():65-94. PubMed ID: 1324134
[No Abstract] [Full Text] [Related]
16. Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes.
Arab S; Lingwood CA
Glycoconj J; 1996 Apr; 13(2):159-66. PubMed ID: 8737240
[TBL] [Abstract][Full Text] [Related]
17. Capping and receptor-mediated endocytosis of cell-bound verotoxin (Shiga-like toxin). 1: Chemical identification of an amino acid in the B subunit necessary for efficient receptor glycolipid binding and cellular internalization.
Khine AA; Lingwood CA
J Cell Physiol; 1994 Nov; 161(2):319-32. PubMed ID: 7962116
[TBL] [Abstract][Full Text] [Related]
18. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.
Lingwood CA; Law H; Richardson S; Petric M; Brunton JL; De Grandis S; Karmali M
J Biol Chem; 1987 Jun; 262(18):8834-9. PubMed ID: 3298243
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility to verotoxin as a function of the cell cycle.
Pudymaitis A; Lingwood CA
J Cell Physiol; 1992 Mar; 150(3):632-9. PubMed ID: 1537890
[TBL] [Abstract][Full Text] [Related]
20. Alpha-galactose based neoglycopeptides. Inhibition of verotoxin binding to globotriosylceramide.
Arya P; Kutterer KM; Qin H; Roby J; Barnes ML; Lin S; Lingwood CA; Peter MG
Bioorg Med Chem; 1999 Dec; 7(12):2823-33. PubMed ID: 10658586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
